Hypertriglyceridemic subjects exhibit an accumulation of small dense chylomicron particles in the fasting state

Atherosclerosis

Volumn 243, Issue 1, 2015, Pages 236-241

  Irawati, Deasy ^a,b   Mamo, John C L ^a   Soares, Mario J ^a   Slivkoff Clark, Karin M ^a   James, Anthony P ^a  

^a CURTIN UNIVERSITY   (Australia)

^b Mataram University   (Indonesia)

Author keywords

Apolipoprotein B 48; Chylomicron; Hypertriglyceridemia; Lipoprotein fraction

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CHOLESTEROL; CHYLOMICRON; GLUCOSE; INSULIN; LIPID; LIPOPROTEIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; MIDDLE AGED; PARTICLE SIZE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; AGED; ANALYSIS; ANTHROPOMETRY; BLOOD; CROSS-SECTIONAL STUDY; GLUCOSE BLOOD LEVEL; RISK FACTOR;

AGED; ANTHROPOMETRY; APOLIPOPROTEIN B-100; APOLIPOPROTEIN B-48; BLOOD GLUCOSE; CHYLOMICRONS; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; PARTICLE SIZE; RISK FACTORS; TRIGLYCERIDES;

EID: 84942241842     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.09.018     Document Type: Article

References (49)

1. Boullart A.C.I., de Graaf J., Stalenhoef A.F. Serum triglycerides and risk of cardiovascular disease. Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids 2012, 1821(5):867-875.
2. Masuda D., et al. Correlation of fasting serum apolipoprotein B-48 with coronary artery disease prevalence. Eur. J. Clin. Invest. 2012, 42(9):992-999.
3. Alipour A., et al. Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice. Eur. J. Clin. Invest. 2012, 42(7):702-708.
4. Pal S., et al. Identification of lipoproteins of intestinal origin in human atherosclerotic plaque. Clin. Chem. Lab. Med. 2003, 41(6):792-795.
5. Nakano T., et al. Detection of apolipoproteins B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases. Clin. Chim. Acta 2008, 390(1-2):38-43.
6. Guo Q., Kohen Avramoglu R., Adeli K. Intestinal assembly and secretion of highly dense/lipid-poor apolipoprotein B48-containing lipoprotein particles in the fasting state: evidence for induction by insulin resistance and exogenous fatty acids. Metab. Clin. Exp. 2005, 54(5):689-697.
7. Zheng C., et al. Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat. J. Lipid Res. 2006, 47(8):1771-1779.
8. Mamo J.C.L., Proctor S.D., Smith D. Retention of chylomicron remnants by arterial tissue; importance of an efficient clearance mechanism from plasma. Atherosclerosis 1998, 141(Suppl. 1):S63-S69.
9. McPherson R. Remnant cholesterol: "Non-(HDL-C + LDL-C)" as a coronary artery disease risk factor. J. Am. Coll. Cardiol. 2013, 61(4):437-439.
10. Napolitano M., et al. The internal redox balance of the cells influences the metabolism of lipids of dietary origin by J774 macrophages: implications for foam cell formation. J. Vasc. Res. 2001, 38(4):350-360.
11. Proctor S.D., Mamo J.C.L. Arterial fatty lesions have increased uptake of chylomicron remnants but not low-density lipoproteins. Coron. Artery Dis. 1996, 7(3):239-245.
12. Proctor S.D., Vine D.F., Mamo J.C.L. Arterial retention of apolipoprotein B48- and B100-containing lipoproteins in atherogenesis. Curr. Opin. Lipidol. 2002, 13(5):461-470.
13. van Lenten B.J., et al. Receptor-mediated uptake of remnant lipoproteins by cholesterol-loaded human monocyte-macrophages. J. Biol. Chem. 1985, 260(15):8783-8788.
14. Flood C., et al. Identification of the proteoglycan binding site in apolipoprotein B48. J. Biol. Chem. 2002, 277(35):32228-32233.
15. Simionescu N. Cellular aspects of transcapillary exchange. Physiol. Rev. 1983, 63(4):1536-1579.
16. Stender S., Zilversmit D.B. Transfer of plasma lipoprotein components and of plasma proteins into aortas of cholesterol-fed rabbits. molecular size as a determinant of plasma lipoprotein influx. Arteriosclerosis 1981, 1(1):38-49.
17. James A.P., Slivkoff-Clark K., Mamo J.C.L. New insights into cardiovascular disease risk in subjects with visceral obesity. Asia Pac. J. Public Health 2003, 15(Suppl. L.):S37-S40.
18. Mamo J.C.L., et al. Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?. Am. J. Physiol. Endocrinol. Metab. 2001, 281(3 44-3):E626-E632.
19. Lam V., et al. The serum concentration of the calcium binding protein S100B is positively associated wtih cognitive performance in older adults. Front. Aging Neurosci. 2013, 5:1-6. (article 61).
20. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation 2002, 106(25):3143-3421.
21. Karpe F., et al. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J. Clin. Invest. 1993, 91(3):748-758.
22. Altman D.G. Statistics and ethics in medical research. III. How large a sample?. Br. Med. J. 1980, 281(6251):1336-1338.
23. Norton K., Olds T. Anthropometrica 2000, University of New South Wales Press, Sydney, Australia.
24. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 1955, 34:1345-1353.
25. James A.P., Mamo J.C. Consumption of low doses of fat prevents the postprandial rise in chylomicron particle concentration and remnant accumulation in healthy normolipidaemic males. J. Nutr. Sci. 2012, 1:1-8.
26. Bairaktari E., et al. Estimation of LDL cholesterol based on the friedewald formula and on apo B levels. Clin. Biochem. 2000, 33(7):549-555.
27. Matthews D.R., Hosker J.P., Rudenski A.S. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419.
28. Kinoshita M., et al. Determination of apolipoprotein B-48 in serum by a sandwich ELISA. Clin. Chim. Acta 2005, 351(1-2):115-120.
29. Campos H., Khoo C., Sacks F.M. Diurnal and acute patterns of postprandial apolipoprotein B-48 in VLDL, IDL, and LDL from normolipidemic humans. Atherosclerosis 2005, 181(2):345-351.
30. Fielding C.J. Lipoprotein receptors, plasma cholesterol metabolism, and the regulation of cellular free cholesterol concentration. FASEB J. 1992, 6(13):3162-3168.
31. Hassing H.C., et al. Pathophysiology of hypertriglyceridemia. Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids 2012, 1821(5):826-832.
32. Karpe F., Hellénius M.L., Hamsten A. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease. Metab. Clin. Exp. 1999, 48(3):301-307.
33. Ruderman N.B., Richards K.C., Valles de Bourges V. Regulation of production and release of lipoprotein by the perfused rat liver. J. Lipid Res. 1968, 9(5):613-619.
34. Després J.-P., et al. Correlates of plasma very-low-density lipoprotein concentration and composition in premenopausal women. Metabolism 1990, 39(6):577-583.
35. Xiao C., et al. Gut-liver interaction in triglyceride-rich lipoprotein metabolism. Am. J. Physiol. Endocrinol. Metab. 2011, 301(3):E429-E446.
36. Shojaee-Moradie F., et al. Prandial hypertriglyceridemia in metabolic syndrome is due to an overproduction of both chylomicron and VLDL Triacylglycerol. Diabetes 2013, 62(12):4063-4069.
37. Sniderman A.D., et al. Phenotypes of hypertriglyceridemia caused by excess very-low-density lipoprotein. J. Clin. Lipidol. 2012, 6(5):427-433.
38. Eisenberg S., et al. Abnormalities in very low, low, and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment. J. Clin. Invest. 1984, 74(2):470-482.
39. Maheux P., et al. Relationship between insulin-mediated glucose disposal and regulation of plasma and adipose tissue lipoprotein lipase. Diabetologia 1997, 40(7):850-858.
40. Chen K., et al. Metabolic factors in type 2 diabetes augment hepatocyte expression of SULF2, a novel suppressor of remnant lipoprotein uptake. Circulation 2009, 120:S1175.
41. Williams K.J., Chen K. Recent insights into factors affecting remnant lipoprotein uptake. Curr. Opin. Lipidol. 2010, 21(3):218-228.
42. Talayero B.G., Sacks F.M. The role of triglycerides in atherosclerosis. Curr. Cardiol. Rep. 2011, 13(6):544-552.
43. Nordestgaard B.G., Tybjaerg-Hansen A., Lewis B. Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits: roles of plasma concentration, extent of aortic lesion, and lipoprotein particle size as determinants. Arterioscler. Thromb. 1992, 12(1):6-18.
44. Shaikh M., et al. Quantitative studies of transfer in Vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans. Arterioscler. Thromb. Vasc. Biol. 1991, 11(3):569-577.
45. Mamo J.C.L., Wheeler J.R. Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein, and albumin. Coron. Artery Dis. 1994, 5(8):695-705.
46. Boquist S., et al. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. Circulation 1999, 100(7):723-728.
47. Karpe F., et al. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100. Arterioscler. Thromb. Vasc. Biol. 1995, 15(2):199-207.
48. Mills G.L., Lane P.A., Weech P.K. A guidebook to lipoprotein technique. Laboratory Techniques in Biochemistry and Molecular Biology 1984, 3. Elsevier, Amsterdam, New York, Oxford. R.H. Burdon, P.H. van Knippenberg (Eds.).
49. Simionescu N., Simionescu M. Interactions of endogenous lipoproteins with capillary endothelium in spontaneously hyperlipoproteinemic rats. Microvasc. Res. 1985, 30(3):314-332.